A Study of Multiple Ascending Doses MY008211A in Healthy Adults

Summary

This is a single-center, randomized, double-blind, placebo-controlled, dose-escalation, and multiple-dose study to evaluate safety, tolerability, PK and PD of MY008211A Tablets in healthy subjects.

Timeline

Start

2023-01-10

Primary completion

2023-06-30

Completion

2023-06-30

Drugs

Indications